Inventor · disambiguated record
Cornelis G. Kruse
Also filed as: KRUSE CORNELIS · KRUSE CORNELIS G · KRUSE CORNELIS GERRIT
55 granted patents·14 pending applications·457 citations·filing 1985–2014
98Inventor score
Files withSOLVAY PHARM BV29DUPHAR INT RES17LANGE JOSEPHUS H M3SOLVAY PHARMACEUTICALS INC3STOIT AXEL3
Top patents by PatentIndex Score
69 records- 0192US6476060B24,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2001·Granted Nov 5, 2002·78 cites·24 claims
- 0287US6974810B24,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activitySOLVAY PHARM BV·Filed 2002·Granted Dec 13, 2005·31 cites·9 claims
- 0386US7728018B2Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonistsSOLVAY PHARM BV·Filed 2007·Granted Jun 1, 2010·11 cites·11 claims
- 0486US7524867B2Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivitySOLVAY PHARM BV·Filed 2005·Granted Apr 28, 2009·10 cites·11 claims
- 0584US8252930B2Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibitionSTOIT AXEL·Filed 2010·Granted Aug 28, 2012·9 cites·4 claims
- 0683US5424313ABibyclic heteroacrylpiperazine derivatives having psychotropic activity, and pharmaceutical compositions containing these derivativesDUPHAR INT RES·Filed 1993·Granted Jun 13, 1995·62 cites·7 claims
- 0782US7528162B24,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2002·Granted May 5, 2009·20 cites·16 claims
- 0882US4782061AMethod of treating psychotropic conditions employing substituted piperazine compoundsDUPHAR INT RES·Filed 1985·Granted Nov 1, 1988·38 cites·2 claims
- 0981US7109216B21H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activitySOLVAY PHARM BV·Filed 2004·Granted Sep 19, 2006·14 cites·13 claims
- 1080US4772604APhenyl-substituted (N-piperazinyl) methylazoles for treating affections in the central nervous systemDUPHAR INT RES·Filed 1987·Granted Sep 20, 1988·26 cites·3 claims
- 1179US7319110B21H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activitySOLVAY PHARM BV·Filed 2003·Granted Jan 15, 2008·14 cites·4 claims
- 1278US6828325B2PhenylpiperazinesSOLVAY PHARM BV·Filed 2002·Granted Dec 7, 2004·13 cites·5 claims
- 1377US8138174B2Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibitionLANGE JOSEPHUS H M·Filed 2008·Granted Mar 20, 2012·2 cites·5 claims
- 1476US7786144B2Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonistsSOLVAY PHARM BV·Filed 2007·Granted Aug 31, 2010·2 cites·13 claims
- 1576US7608718B24,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted Oct 27, 2009·2 cites·2 claims
- 1675US7964728B2Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibitionSOLVAY PHARM BV·Filed 2007·Granted Jun 21, 2011·2 cites·7 claims
- 1771US6911448B2Piperazine and piperidine compoundsSOLVAY PHARM BV·Filed 2001·Granted Jun 28, 2005·5 cites·10 claims
- 1871US6214829B1Piperazine compounds, their preparation, and methods of using themDUPHAR INT RES·Filed 1998·Granted Apr 10, 2001·34 cites·8 claims
- 1970US7371769B2Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sitesSOLVAY PHARM BV·Filed 2005·Granted May 13, 2008·1 cites·18 claims
- 2070US7186741B2Neurotensin active 2,3,diaryl-pyrazolidine derivativesSOLVAY PHARM BV·Filed 2003·Granted Mar 6, 2007·6 cites·4 claims
- 2169US8563723B2Arylsulfonyl pyrazoline carboxamidine derivatives as 5-HT6 antagonistsVAN LOEVEZIJN ARNOLD·Filed 2009·Granted Oct 22, 2013·2 cites·13 claims
- 2268US8101619B2Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibitionFEENSTRA ROELOF W·Filed 2005·Granted Jan 24, 2012·2 cites·8 claims
- 2367US8063062B2Compounds with a combination of cannabinoid-CB1 antagonism and acetylcholinesterase inhibitionLANGE JOSEPHUS H M·Filed 2007·Granted Nov 22, 2011·1 cites·11 claims
- 2467US7067513B1PhenylpiperazinesSOLVAY PHARM BV·Filed 2000·Granted Jun 27, 2006·3 cites·7 claims
- 2566US8084473B2Heterocyclic compounds with affinity to muscarinic receptorsSTOIT AXEL·Filed 2008·Granted Dec 27, 2011·0 cites·15 claims
- 2662US7605162B2PhenylpiperazineSOLVAY PHARM BV·Filed 2008·Granted Oct 20, 2009·0 cites·6 claims
- 2760US7495108B2Imidazoline derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2007·Granted Feb 24, 2009·0 cites·5 claims
- 2860US6225312B1Piperazine and piperidine compoundsDUPHAR INT RES·Filed 1997·Granted May 1, 2001·20 cites·10 claims
- 2957US8586606B2Heterocyclic compounds with affinity to muscarinic receptorsSTOIT AXEL·Filed 2011·Granted Nov 19, 2013·0 cites·12 claims
- 3057USRE41425EPiperazine and piperidine compoundsDUPHAR INT RES·Filed 2008·Granted Jul 6, 2010·0 cites·12 claims
- 3157US7342032B2Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activitySOLVAY PHARMACEUTICALS INC·Filed 2003·Granted Mar 11, 2008·1 cites·9 claims
- 3257US6090812APiperazine and piperidine compoundsDUPHAR INT RES·Filed 1998·Granted Jul 18, 2000·13 cites·9 claims
- 3356US7456182B2PhenylpiperazinesSOLVAY PHARMACEUTICALS INC·Filed 2006·Granted Nov 25, 2008·0 cites·6 claims
- 3455US8735388B2Heterocyclic compounds with affinity to muscarinic receptorsTERWEL LOUISE·Filed 2013·Granted May 27, 2014·0 cites·12 claims
- 3555US7498348B21 H-imidazole derivatives as cannabinoid receptor modulatorsSOLVAY PHARM BV·Filed 2007·Granted Mar 3, 2009·0 cites·3 claims
- 3655US7173044B2Imidazoline derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted Feb 6, 2007·0 cites·7 claims
- 3755US4874770AAryl-substituted (N-piperidinyl)methyl- and (N-piperidinyl) methylazoles having antipsychotic propertiesDUPHAR INT RES·Filed 1988·Granted Oct 17, 1989·6 cites·4 claims
- 3855US2005124660A1Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compoundsFiled 2004·Application pending·0 cites
- 3954US6391896B13-Tetrahydropyridin-4-yl indoles for treatment of psychotic disordersDUPHAR INT RES·Filed 1999·Granted May 21, 2002·12 cites·7 claims
- 4054US2005143441A1Novel medical combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activityFiled 2004·Application pending·0 cites
- 4154US2005239859A2Novel medical uses of 4,5-dihydro-1h-pyrazole derivatives having cb1- antagonistic activitySOLVAY PHARM GMBH·Filed 2004·Application pending·0 cites
- 4253US7696383B2N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugsSOLVAY PHARM BV·Filed 2008·Granted Apr 13, 2010·0 cites·11 claims
- 4353US7271189B21H-imidazole derivatives as cannabinoid receptor modulatorsSOLVAY PHARM BV·Filed 2004·Granted Sep 18, 2007·0 cites·9 claims
- 4453US2014303372A1Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonistsABBVIE BHAMAS LTD·Filed 2014·Application pending·0 cites
- 4552US7297699B2Piperazine and piperidine compoundsSOLVAY PHARMACEUTICALS INC·Filed 2005·Granted Nov 20, 2007·0 cites·6 claims
- 4651US8729101B21H-imidazole derivative having CB1, agonistic, CB1 partial agonistic or CB1 antagnistic activityKRUSE CORNELIS G·Filed 2008·Granted May 20, 2014·0 cites·6 claims
- 4751US2007259859A1Muscarinic agonists to treat impulse control disordersDE BRUIN NATASJA M W J·Filed 2007·Application pending·0 cites
- 4849US6335326B1Benzisoxazole derivatives having d4-antagonistic activityDUPHAR INT RES·Filed 1999·Granted Jan 1, 2002·9 cites·13 claims
- 4947US2004235854A11H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activityFiled 2002·Application pending·0 cites
- 5047US2008171779A1Use of 5-ht6 antagonists to prevent relapse into addictionSOLVAY PHARM BV·Filed 2008·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →